Your session is about to expire
← Back to Search
Controlled Breathing for POTS
N/A
Recruiting
Led By Satish R Raj, MD, MSCI
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18-60 years
Physician diagnosis of Postural Tachycardia Syndrome (POTS)
Must not have
Subjects who require portable oxygen at rest or with exercise
Subjects with chronic heart failure or severe pulmonary disease who are unable to climb one flight of stairs due to shortness of breath
Timeline
Screening 3 weeks
Treatment Varies
Follow Up difference between hr from supine to peak hr during tilt test for each intervention (mean value hr between the 8th and 9th minute of supine; peak parameters, during hutt, mean value during the first min and between the 3rd and 8th min)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether CO2 can help people with POTS by lowering heart rate and reducing symptoms when upright/standing.
Who is the study for?
This trial is for adults aged 18-60 with a physician's diagnosis of Postural Tachycardia Syndrome (POTS) who can visit the University of Calgary and are non-smokers. Pregnant individuals, those needing portable oxygen, or with severe heart/lung disease, anxiety disorders, or poor past study compliance cannot participate.
What is being tested?
The study tests if controlled breathing using the RespirAct™ system to increase CO2 levels can reduce rapid heartbeat and improve symptoms in POTS patients when standing. The goal is to find the best CO2 level for symptom relief.
What are the potential side effects?
Potential side effects may include discomfort from wearing a mask during the study and possible dizziness or shortness of breath due to changes in CO2 levels while using the RespirAct™ system.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 60 years old.
Select...
I have been diagnosed with POTS by a doctor.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I need portable oxygen for breathing, either at rest or during physical activity.
Select...
I cannot climb stairs without feeling short of breath due to heart or lung problems.
Select...
I have a rapid heartbeat when standing up due to severe dehydration.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ difference between hr from supine to peak hr during tilt test for each intervention (mean value hr between the 8th and 9th minute of supine; peak parameters, during hutt, mean value during the first min and between the 3rd and 8th min)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~difference between hr from supine to peak hr during tilt test for each intervention (mean value hr between the 8th and 9th minute of supine; peak parameters, during hutt, mean value during the first min and between the 3rd and 8th min)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Heart Rate (HR) variation
Secondary study objectives
Cerebral blood flow velocity (CBFv) variation
VOSS symptom score
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment1 Intervention
All participants will receive the same interventions
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
808 Previous Clinical Trials
884,363 Total Patients Enrolled
8 Trials studying Postural Orthostatic Tachycardia Syndrome
637 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
Satish R Raj, MD, MSCIPrincipal InvestigatorUniversity of Calgary, Cardiac Science
4 Previous Clinical Trials
261 Total Patients Enrolled
2 Trials studying Postural Orthostatic Tachycardia Syndrome
157 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need portable oxygen for breathing, either at rest or during physical activity.I am between 18 and 60 years old.I cannot climb stairs without feeling short of breath due to heart or lung problems.I have been diagnosed with POTS by a doctor.I am either male or female.I have a rapid heartbeat when standing up due to severe dehydration.You cannot wear a mask for the whole study.People who do not smoke.You will be excluded if you have severe anxiety or somatization symptoms.
Research Study Groups:
This trial has the following groups:- Group 1: All participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger